Yarlagadda S. Babu
2011
Compensation breakdown
Non-Equity Incentive Plan | $110,028 |
---|---|
Option Awards | $138,500 |
Salary | $323,452 |
Stock Awards | $37,350 |
Other | $12,250 |
Total | $621,580 |
Babu received $323.5K in salary, accounting for 52% of the total pay in 2011.
Babu also received $110K in non-equity incentive plan, $138.5K in option awards, $37.4K in stock awards and $12.3K in other compensation.
Rankings
In 2011, Yarlagadda S. Babu's compensation ranked 7,364th out of 10,747 executives tracked by ExecPay. In other words, Babu earned more than 31.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,364 out of 10,747 | 32nd |
Division Manufacturing | 2,692 out of 3,960 | 32nd |
Major group Chemicals And Allied Products | 661 out of 1,033 | 36th |
Industry group Drugs | 460 out of 781 | 41st |
Industry Biological Products, Except Diagnostic Substances | 78 out of 157 | 50th |
Babu's colleagues
We found five more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2011.
2011
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2011
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2011
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2011
David McCullough
BioCryst Pharmaceuticals
Vice President, Strategic Planning, Commercialization and Corporate Development
2011
Stuart Grant
BioCryst Pharmaceuticals